Valerio Gelfo, Michela Sgarzi, Maria Mazzarini, Francesca Pontis, Gabriele D’Uva, Balanz Győrffy, Yosef Yarden, Mattia Lauriola, A novel role for interleukin 1 axis in the resistance to EGFR targeting antibody, in: A novel role for interleukin 1 axis in the resistance to EGFR targeting antibody, 2018, pp. 1 - 2 (atti di: New Technologies and Strategies to fight cancer, Ospedale San Raffaele Milano, 29-31 October 2018) [Abstract]
Gelfo V, Mazzeschi M, Grilli G, Lindzen Moshit, Santi Spartaco, D'Uva G, Győrffy B, Ardizzoni A, Yarden Y, Lauriola M., A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy, «CANCERS», 2018, 10, pp. 355 - 370 [Scientific article]
Valerio Gelfo, Giada Grilli, Martina Mazzeschi, Moshit Lindzen, Rossella Solmi, Gabriele. D’Uva, Balazs. Győrffy, Yosef Yarden, Mattia Lauriola., Modulation of ERBB signaling from tissue homeostasis to cancer progression, in: Modulation of ERBB signaling from tissue homeostasis to cancer progression, 2018, pp. 1 - 1 (atti di: Sessione Scientifica, Collegio dei Docenti di Istologia e Embriologia, Roma, 23 Febbraio 2018) [Abstract]
Valerio Gelfo, Giada Grilli, Martina Mazzeschi, Moshit Lindzen, Spartaco Santi, Gabriele D’Uva, Yosef Yarden, Mattia Lauriola, Molecular mechanisms of resistance to cetuximab mediated by IL-1 signaling, in: Molecular mechanisms of resistance to cetuximab mediated by IL-1 signaling, 2018, pp. 1 - 1 (atti di: ABCD National Ph.D. Meeting, Salerno, 22-24 March 2018) [Contribution to conference proceedings]
Valerio Gelfo, Martina Mazzeschi, Giada Grilli, Moshit Lindzen, Rossella Solmi, Gabriele D’Uva, Yosef Yarden, Mattia Lauriola, A putative role for interleukin 1 pathway in resistance to EGFR blockade, in: A putative role for interleukin 1 pathway in resistance to EGFR blockade, 2017, pp. 1 - 1 (atti di: 1st European Alliance of Personalized Medicine Congress, Belfast, 27-30 Nov 2017) [Contribution to conference proceedings]
Valerio Gelfo, Michela Pucci, Moshit Lindzen, Martina Mazzeschi, Massimiliano Bonafè,
Rossella Solmi, Gabriele D’Uva, Yosef Yarden, Mattia Lauriola, Mechanisms of acquired resistance to cetuximab: role of interleukin-1, in: Mechanisms of acquired resistance to cetuximab: role of interleukin-1, 2017, pp. 132 - 132 (atti di: 2nd Special Conference EACR-AACR-SIC, The Challenges of Optimising Immuno- and Targeted Therapies: from Cancer Biology to the Clinic, Florence, 24-27 June 2017) [Abstract]
Valerio Gelfo, Michela Pucci, Moshit Lindzen, Maria Teresa Rodia, Rossella Solmi, Massimiliano Bonafè, Elisabetta Caramelli, Yosef Yarden, Mattia Lauriola, Mechanisms of acquired resistance to cetuximab: role of interleukin-1, in: Mechanisms of acquired resistance to cetuximab: role of interleukin-1, 2017, pp. 1 - 1 (atti di: 11° Seminario dei Ricercatori – Centro Unificato di Ricerca Biomedica Applicata (CRBA), Bologna, 22/05/2017) [Contribution to conference proceedings]
Gelfo, Valerio; Rodia, Maria Teresa; Pucci, Michela; Dall'Ora, Massimiliano; Santi, Spartaco; Solmi, Rossella; Roth, Lee; Lindzen, Moshit; Bonafè, Massimiliano; Bertotti, Andrea; Caramelli, Elisabetta; Lollini, Pier-Luigi; Trusolino, Livio; Yarden, Yosef; D'Uva, Gabriele; Lauriola, Mattia, A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors, «ONCOTARGET», 2016, 7, pp. 72167 - 72183 [Scientific article]
Nicoletta Macrì, Valerio Gelfo, Davide D’Urso, Massimiliano Bonafè, Mattia Lauriola, Adriana Albini, D’Uva Gabriele, ERBB RECEPTORS DIMERIZATION DEFINES BREAST CANCERS SUBTYPES AND CLINICAL OUTCOMES: IMPLICATION FOR CANCER THERAPIES, in: ERBB RECEPTORS DIMERIZATION DEFINES BREAST CANCERS SUBTYPES AND CLINICAL OUTCOMES: IMPLICATION FOR CANCER THERAPIES, 2016(atti di: 4th INTERNATIONAL CONFERENCE TRANSLATIONAL RESEARCH IN ONCOLOGY, Forli, 8-11/11/2016) [Poster]
Valerio Gelfo, Michela Pucci, Moshit Lindzen, Maria Teresa Rodia, Rossella Solmi, Massimiliano Bonafè, Elisabetta Caramelli, Yosef Yarden, Mattia Lauriola., Mechanisms of acquired resistance to cetuximab: role of interleukin 1, in: Mechanisms of acquired resistance to cetuximab: role of interleukin 1, 2016, pp. 1 - 1 (atti di: 4th INTERNATIONAL CONFERENCE TRANSLATIONAL RESEARCH IN ONCOLOGY, Forli, 8-11/11/2016) [Contribution to conference proceedings]
